Acura Pharma (ACUR) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts ACUR Hot Sheet
Price: $0.01 --0%
Financial Fact:
Marketing, general and administrative: 1.34M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Marketing, general and administrative: 1.34M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Acura Pharma (NASDAQ: ACUR) reported Q1 EPS of $0.03, $0.04 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $5.4 million versus the consensus estimate of $7.6 million.
For earnings history and earnings-related data on Acura Pharma (ACUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Universal Logistics Holdings, Inc. (ULH) Tops Q1 EPS by 136c
- COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
